High incidence and prevalence of multiple sclerosis in south east Scotland: Evidence of a genetic predisposition

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 6, 1998, Pages 730-735

  Rothwell, P M ^a,b   Charlton, D ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Epidemiology; Latitude; Multiple sclerosis; Prevalence

Indexed keywords

ARTICLE; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MULTIPLE SCLEROSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0031748176     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.6.730     Document Type: Article

References (26)

1. Ebers GC, Sadovnick AD. The geographic distribution of multiple sclerosis: a review. Neuroepidemiology 1993;12:1-5.
2. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Micrbiol Rev 1993;6:382-427.
3. Compston DAS, Ebers GC. The genetics of multiple sclerosis. In: Cook SD, ed. Handbook of neurology. New York: Decker, 1990;25-39.
4. Bulman D, Ebers G. The geography of multiple sclerosis reflects genetic susceptibility. J Trop Geogr Neurol 1992;2: 66-72.
5. Skegg DCG, Corwin PA, Craven RS, et al. Occurence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry 1987;50:134-9.
6. Hammond SR, Mcleod JG, Milligen KS, et al. The epidemiology in three Australian cities: Perth, Newcastle, and Hobart. Brain 1988;111:1-25.
7. Swingler RJ, Compston DAS. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1986;49:1115-24.
8. Sutherland JM. Observations on the prevalence of multiple sclerosis in northern Scotland. Brain 1956;79:635-54.
9. Fog M, Hyllested K. Prevalence of disseminated sclerosis in the Faroes, the Orkneys, and Shetland. Acta Neurol Scand 1966;24(suppl 19):9-11.
10. Poskanzer DC, Prenney LB, Sheridan JL, et al. Multiple sclerosis in the Orkney and Shetland Islands 1 : epidemiology, clinical factors and methodology. J Epidemiol Community Health 1980;34:229-39.
11. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS. Neurology 1986;36:307-28.
12. Rice-Oxley M, Williams ES, Rees J. A prevalence survey of multiple sclerosis in Sussex. J Neurol Neurosurg Psychiatry 1995;58:27-30.
13. Shepherd DI, Summers A. Prevalence of multiple sclerosis in Rochdale. J Neurol Neurosurg Psychiatry 1996;61:415-17.
14. Williams ES, McKerron RO. Prevalence of multiple sclerosis in a South London borough. BMJ 1986;293:237-9.
15. Mumford CJ, Fraser MB, Wood NW, et al. Multiple sclerosis in the Cambridge health district of East Anglia. J Neurol Neurosurg Psychiatry 1992;55:877-82.
16. Roberts MHW, Martin JP, Mclellan DL, et al. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority, J Neurol Neurosurg Psychiatry 1991;54:55-9.
17. Swingler RJ, Compston DAS. The prevalence of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 1988;51:1520-4.
18. Robertson N, Compston A. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995;58:2-6.
19. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
20. Millar JHD. Multiple sclerosis in Northern Ireland. In: Clifford Rose F, ed. Clinical neuroepidemiology. Tunbridge Wells: Pitman Medical, 1980:222-7.
21. Schoenberg BS. Calculating confidence intervals for rates and ratios. Neuroepidemiology 1983;2:314-16.
22. Guppy HB. Homes of family names in Great Britain. London: Harrison, 1980.
23. Shepherd DI, Downie AW. A further prevalence study of multiple sclerosis in north east Scotland. J Neurol Neurosurg Psychiatry 1980;43:310-5.
24. Swingler RJ, Rothwell PM, Taylor MW, et al. The prevalence of multiple sclerosis in 604 general practices in the United Kingdom. Ann Neurol 1994;36:303.
25. Rothwell PM, Carstairs V, Elton R, et al. Regional variations in the distribution of multiple sclerosis in Scotland. Ann Neurol 1946;36:302.
26. Miller DH, Hammond SR, McLeod JG, et al. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J Neurol Neurosurg Psychiatry 1990:53:903-5.